This ultimate goal of this project is to develop advanced drug delivery systems, which combat diseases by effectively sending "targeted bombs" to disease sites. Project is Not Currently Available This ...

Gastroretentive drug delivery systems (GRDDS) represent a sophisticated approach to oral medication by extending the retention time of dosage forms in the stomach. This increased residence time can ...

Glycyrrhizic acid, a triterpene glycoside derived from licorice root, exhibits remarkable amphiphilicity that facilitates the formation of host–guest complexes with hydrophobic drugs. This unique ...

Mycrodose Therapeutics is widely recognized as the first company to bring Advanced Drug Delivery Technologies (ADD) into the Psychedelic Medicine Sector. "The confidence shown by investors regarding ...

Objective: To provide commentary and reviews and brief discussions in controversial or innovative recent advances in neonatal pharmacotherapy. To discuss cutting edge drug delivery systems that may ...

An Australian research team has achieved an advanced materials breakthrough that opens the door to a new generation of nanodrug applications. From drug delivery, to diagnostics, to gene editing and ...

Annette Bak, PhD is the Head, Advanced Drug Delivery, Pharmaceutical Sciences, R&D, at AstraZeneca. What are you focusing on now in your work? I lead the Advanced Drug Delivery department within ...

Nanogels are increasingly used in drug delivery systems for their ability to encapsulate a wide range of therapeutic agents and release them in a controlled, targeted manner. Recent developments have ...

The rise in the use and advancement of biologics and personalized medicine, along with a shift towards home-based treatments, is driving a surge in the production and innovation of drug delivery ...

VANCOUVER, BC / ACCESSWIRE / December 2, 2024 / BioNxt Solutions Inc. ("BioNxt" or the "Company") (CSE:BNXT)(OTC PINK:BNXTF)(FSE:BXT), a bioscience company specializing in advanced drug delivery ...

Robert Langer is a professor of chemical and biomedical engi neering at the Massachusetts Institute of Technology. He has written more than 800 articles, has more than 500 issued or pending patents ...

DUBLIN--(BUSINESS WIRE)--The "Molecular Switches As Therapeutic Targets, Drug Development, Drug Delivery Mechanism & Application By Indications Insight 2025" report has been added to ...